thyroxine has been researched along with Lymphocytosis in 4 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Central diabetes insipidus was diagnosed by water deprivation test." | 1.34 | Lymphocytic panhypophysitis in a young man with involvement of the cavernous sinus and clivus. ( Bilgic, B; Kartal, I; Tanakol, R; Yarman, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez-Cuyar, LF | 1 |
| Tavora, F | 1 |
| Shaw, K | 1 |
| Castellani, RJ | 1 |
| Dejong, JL | 1 |
| Kartal, I | 1 |
| Yarman, S | 1 |
| Tanakol, R | 1 |
| Bilgic, B | 1 |
| Ozawa, Y | 1 |
| Shishiba, Y | 1 |
| Phan, GQ | 1 |
| Attia, P | 1 |
| Steinberg, SM | 1 |
| White, DE | 1 |
| Rosenberg, SA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma[NCT03918252] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-10-02 | Recruiting | ||
| Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.[NCT02259621] | Phase 2 | 45 participants (Anticipated) | Interventional | 2014-09-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for thyroxine and Lymphocytosis
| Article | Year |
|---|---|
Sudden unexpected death in lymphocytic hypophysitis.
Topics: Adrenal Medulla; Death, Sudden; Female; Forensic Pathology; Humans; Lymphocytosis; Pituitary Disease | 2009 |
Lymphocytic panhypophysitis in a young man with involvement of the cavernous sinus and clivus.
Topics: Adult; Autoimmune Diseases; Cavernous Sinus; Cranial Fossa, Posterior; Deamino Arginine Vasopressin; | 2007 |
Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Autoantibodies; Autoimmune | 1993 |
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Inject | 2001 |
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Inject | 2001 |
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Inject | 2001 |
Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Inject | 2001 |